Team Careers Products Medical Affairs News Contact

Team Careers Products Medical Affairs News Contact

Back

Population pharmacokinetic analyses for sulbactam-durlobactam using Phase 1, 2, and 3 data

December 19, 2024

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

Team Careers Products Medical Affairs - Report Adverse Events - Report Product Complaints News Contact

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

© 2025 INNOVIVA SPECIALTY THERAPEUTICS | ALL RIGHTS RESERVED